Eli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in July. It is working on additional approvals. Mounjaro's global sales exceeded $3.1 billion in Q3 2024. Lilly will expand its diabetes portfolio in India with this launch. It has partnerships with Lupin and Cipla for other diabetes products.
